Jack W Callicutt Galectin Therapeutics Inc (GALT) insider trading activity

Jack W Callicutt is Chief Financial Officer of GALECTIN THERAPEUTICS INC. Currently has a direct ownership of 7,614 shares of GALT, which is worth approximately $41,877. The most recent transaction as insider was on Nov 18, 2025, when has been sold 46,310 shares (Common Stock) at a price of $6.22 per share, resulting in proceeds of $288,048. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.61K

0% 3M change

0% 12M change

Total Value Held $41,877

JACK W CALLICUTT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2025	SELL Open market or private sale	$288,048 $6.22 p/Share	46,310 Reduced 85.88%	7,614 Common Stock
Nov 18 2025	BUY Exercise of conversion of derivative security	$71,780 $1.55 p/Share	46,310 Added 64.2%	25,824 Common Stock
Nov 17 2025	SELL Open market or private sale	$190,608 $6.03 p/Share	31,610 Reduced 80.59%	7,614 Common Stock
Nov 17 2025	BUY Exercise of conversion of derivative security	$45,518 $1.44 p/Share	31,610 Added 76.08%	9,937 Common Stock
Nov 10 2025	SELL Open market or private sale	$31,904 $6.03 p/Share	5,291 Reduced 41.0%	7,614 Common Stock
Nov 10 2025	BUY Exercise of conversion of derivative security	$7,619 $1.44 p/Share	5,291 Added 36.14%	9,350 Common Stock
Nov 05 2025	SELL Open market or private sale	$3,600 $6.0 p/Share	600 Reduced 7.3%	7,614 Common Stock

Nov 05 2025	BUY Exercise of conversion of derivative security	$960 $1.6 p/Share	600 Added 7.13%	7,814 Common Stock
Nov 04 2025	SELL Open market or private sale	$173,778 $6.07 p/Share	28,629 Reduced 78.99%	7,614 Common Stock
Nov 04 2025	BUY Exercise of conversion of derivative security	$45,806 $1.6 p/Share	28,629 Added 60.93%	18,355 Common Stock
Nov 03 2025	SELL Open market or private sale	$15,385 $6.01 p/Share	2,560 Reduced 25.16%	7,614 Common Stock
Nov 03 2025	SELL Open market or private sale	$7,512 $6.01 p/Share	1,250 Reduced 14.1%	7,614 Commno stock
Nov 03 2025	BUY Exercise of conversion of derivative security	$6,096 $1.6 p/Share	3,810 Added 30.06%	8,864 Common Stock
Sep 12 2025	SELL Open market or private sale	$56,066 $6.44 p/Share	8,706 Reduced 53.35%	7,614 Common Stock
Sep 12 2025	BUY Exercise of conversion of derivative security	$11,927 $1.37 p/Share	8,706 Added 34.79%	16,320 Common Stock
Dec 23 2024	SELL Open market or private sale	$35,600 $0.89 p/Share	40,000 Reduced 84.01%	7,614 Common Stock
Dec 23 2024	BUY Exercise of conversion of derivative security	-	40,000 Added 45.65%	47,614 Common Stock
Nov 17 2022	BUY Open market or private purchase	$5,280 $1.32 p/Share	4,000 Added 34.44%	7,614 Common Stock

JWC

Jack W Callicutt

Chief Financial Officer

Norcross, GA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GALT shares.

Notify only if

Value

Insider Trading

Get notified when an Galectin Therapeutics Inc insider buys or sells GALT shares.

Notify only if

Operation

Value

Type

News

Receive news related to GALECTIN THERAPEUTICS INC

Track Activities on GALT

Account